Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Members of the inflammatory breast cancer community — including physician-scientists, patients, and their loved ones — gathered virtually in April 2021 for an online event focused on education, support, and celebration. Below are some highlights from the annual forum.
Dana-Farber IBC Program 10-Year Celebration and Virtual Forum | IntroductionEric P. Winer, MD, and Beth Overmoyer, MD, FACP, welcome attendees to the Dana-Farber Inflammatory Breast Cancer Program 10-Year Celebration and Educational Virtual Forum.
Dana-Farber Inflammatory Breast Cancer Program | Celebrating 10 Years of Progress and InnovationBeth Overmoyer, MD, and Filipa Lynce, MD, along with their colleagues and patients, celebrate the advances in research, treatment, and support in the decade since the IBC Program was founded.
Dana-Farber IBC Program 10-Year Celebration and Virtual Forum | New Diagnostic Criteria for IBCFilipa Lynce, MD, outlines updated criteria for diagnosing inflammatory breast cancer.
Dana-Farber IBC Program 10-Year Celebration and Virtual Forum | IBC Research UpdateGuest speaker Wendy Woodward MD, PhD, of the University of Texas MD Anderson Cancer Center provides an overview of progress and gaps in inflammatory breast cancer research and treatment.
Dana-Farber IBC Program 10-Year Celebration and Virtual Forum | Biography of IBC: From Rare to CareGuest speaker Gayathri R. Devi, PhD, of Duke University School of Medicine discusses ongoing efforts to better understand inflammatory breast cancer.
Dana-Farber IBC Program 10-Year Celebration and Virtual Forum | Optical Genome MappingGuest speaker Justin Balko, PharmD, PhD, of Vanderbilt University Medical Center discusses optical genome mapping of large structural variations in non-inflammatory and inflammatory breast cancer.
Dana-Farber IBC Program 10-Year Celebration and Virtual Forum | Cancer Treatments and the BrainGuest speaker Stephanie Tung, MD, of Harvard Medical School discusses the effects of chemotherapy and other cancer therapies on the brain in the Patient-Centered Care portion of the event.
Dana-Farber IBC Program 10-Year Celebration and Virtual Forum | Reconstructive Surgery and LymphedemaGuest speakers Justin Broyles, MD, and Shailesh Agarwal, MD, of Brigham and Women's Hospital discuss the role of reconstructive surgery in breast cancer lymphedema in the Patient-Centered Care portion of the event.
Dana-Farber IBC Program 10-Year Celebration and Virtual Forum | Lessons Learned Post-MastectomyPatient advocate Trish Vickery shares her journey with inflammatory breast cancer, and the lessons she has learned about navigating her "new normal" in the Patient-Centered Care portion of the event.
Dana-Farber IBC Program 10-Year Celebration and Virtual Forum | Patient-Centered Care Q&A SessionSpeakers in the Patient-Centered Care portion of the Dana-Farber Inflammatory Breast Cancer Program 10-Year Celebration and Educational Virtual Forum answer questions from event attendees.
New Patient Appointments 877-442-3324
Highlights from the 2019 Inflammatory Breast Cancer Forum If you were unable to attend the 2019 Forum, you may view highlights from the event.
If you were unable to attend the 2019 Forum, you may view highlights from the event.